Trademark: 98388195
Word
EPIWRITE
Status
Pending
Status Code
645
Status Date
Tuesday, August 27, 2024
Serial Number
98388195
Mark Type
4
Filing Date
Friday, February 2, 2024
Trademark Owner History
Moonwalk Biosciences
Classifications
5 Pharmaceutical preparations and substances for the treatment of human, veterinary, and plant diseases and disorders using epigenetic editing technologies, gene therapy, gene editing, and nucleic acids, alone or in combination with small molecules.
42 Research and development in the field of pharmaceuticals, therapeutics, and biotechnology; Conducting research and clinical trials for others relating to pharmaceuticals in the field of human, veterinary, and plant diseases and disorders using epigenetic editing technologies, gene therapy, gene editing, and nucleic acids, alone or in combination with small molecules.
Trademark Events
Feb 6, 2024
New Application Entered
May 23, 2024
Non-Final Action Written
Feb 29, 2024
New Application Office Supplied Data Entered
May 22, 2024
Assigned To Examiner
May 23, 2024
Non-Final Action E-Mailed
May 23, 2024
Notification Of Non-Final Action E-Mailed
Aug 19, 2024
Correspondence Received In Law Office
Aug 19, 2024
Teas/Email Correspondence Entered
Aug 19, 2024
Teas Response To Office Action Received
Aug 27, 2024
Final Refusal Written
Aug 27, 2024
Final Refusal E-Mailed
Aug 27, 2024
Notification Of Final Refusal Emailed
BYTEMEDIC
BRETON
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - Twit Solutions PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov